Case-control study for colorectal cancer genetic susceptibility in EPICOLON: previously identified variants and mucins.
Case-control study for colorectal cancer genetic susceptibility in EPICOLON: previously identified variants and mucins.
Tipus de Publicació:
Journal ArticleOrígen:
BMC cancer, Volume 11, p.339 (2011)URL:
http://www.biomedcentral.com/1471-2407/11/339Resum:
Colorectal cancer (CRC) is the second leading cause of cancer death in developed countries. Familial aggregation in CRC is also important outside syndromic forms and, in this case, a polygenic model with several common low-penetrance alleles contributing to CRC genetic predisposition could be hypothesized. Mucins and GALNTs (N-acetylgalactosaminyltransferase) are interesting candidates for CRC genetic susceptibility and have not been previously evaluated. We present results for ten genetic variants linked to CRC risk in previous studies (previously identified category) and 18 selected variants from the mucin gene family in a case-control association study from the Spanish EPICOLON consortium.
Pubmed ID: 21819567




